Young Scientist Receives €1.1M to Study Brain Tumors with Quantum Physics & 3D Bioprinting
Brescia-Based Researcher Receives Over €1 Million to Study Glioblastoma
A young researcher from Brescia, Italy, Dr. Giada Bianchetti, has been awarded a significant grant exceeding €1.1 million from the Italian Scientific Foundation (Fondo italiano per la Scienza) to lead her own research group. This funding will support a five-year project investigating glioblastoma multiforme, an aggressive form of brain cancer, at the University Cattolica del Sacro Cuore’s I-Lamp laboratories. The grant aims to support young scientists establish independent research careers, and in Dr. Bianchetti’s case, will facilitate the development of innovative approaches to understanding and potentially treating this challenging disease.
A Multidisciplinary Approach to Cancer Research
Dr. Bianchetti’s background is notably interdisciplinary, encompassing physics, neuroscience, and medicine. After completing her physics studies at the Cattolica University of Brescia, she pursued doctoral research in neuroscience in Rome, coupled with specialized training at the Policlinico Gemelli hospital. This experience honed her skills in neuroimaging and established a profile bridging fundamental science and clinical application. Her current project reflects this diverse expertise, bringing together quantum physics, bioengineering, and oncology to explore the complexities of cancer cell behavior.
Glioblastoma, the most common and aggressive type of brain tumor in adults, presents a significant clinical challenge. Traditional approaches often view tumors as isolated masses, but Dr. Bianchetti’s research recognizes the crucial interplay between the tumor and its surrounding environment. Factors like tissue rigidity and external pressure can profoundly influence how cancer cells behave, a process known as mechanotransduction. This process involves cells converting physical stimuli into biological signals, altering gene expression and impacting proliferation, invasiveness, and treatment resistance. Understanding this mechanism is key to developing more effective therapies.
3D Bioprinting and Quantum Light for Tumor Modeling
The research team will utilize cutting-edge 3D bioprinting technology to create realistic, three-dimensional models of tumors in the laboratory. These models will not only include cancer cells but also recreate the surrounding microenvironment, incorporating components like fibroblasts and endothelial cells to mimic the complex cellular landscape. This allows for precise control over factors like rigidity and pressure, enabling researchers to observe how changes in the external environment affect cancer cell metabolism. Brescia’s Comprehensive Cancer Center will likely be involved in this research, given its established infrastructure.
Metabolism, the process by which cells produce and use energy, is a central focus of the study. As cancer cells develop into more aggressive, they alter their metabolic processes. By analyzing these changes, researchers hope to detect early signs of how the tumor is responding to environmental cues. To achieve this, the team will develop novel observation techniques based on the use of quantum light. They will study the natural fluorescence of molecules like NADH and FAD, which participate in energy production within mitochondria and change behavior depending on the cell’s metabolic state.
The signal from these molecules is very weak, but by employing advanced optical techniques and utilizing quantum-correlated photon pairs, the researchers aim to enhance measurement sensitivity even as minimizing damage to the cells. This approach allows for observations under conditions closer to those found within the body. This builds on existing research into quantum sensing in biological systems, which is a rapidly developing field.
Innovation in Spectroscopic Technologies and Beyond
The project’s innovation lies in two key areas: the development of new spectroscopic technologies based on quantum light and the creation of three-dimensional biological models that accurately replicate the tumor microenvironment. The ultimate goal is to determine whether and how the physical properties of the environment can influence cancer cell metabolism, potentially leading to new therapeutic strategies for complex tumors like glioblastoma.
However, the potential applications extend beyond oncology. The enhanced optical imaging techniques developed during this research could locate use in various other fields, including early disease diagnosis, rapid infection monitoring, and quality control in high-precision industries. The development of these technologies could contribute to advancements in biophotonics, a field focused on the application of light to biological systems.
Building a Collaborative Research Group in Brescia
This funding represents a significant milestone in Dr. Bianchetti’s career and will enable the establishment of a new interdisciplinary research group in Brescia. This group will bring together expertise in physics, biology, and medicine to tackle some of the most complex challenges in biomedical research. The grant will not only cover the cost of equipment and materials but also provide funding for doctoral fellowships and collaborative positions, fostering the next generation of scientists.
The research team’s work promises to deepen our understanding of the intricate relationship between cancer cells and their environment, potentially paving the way for more targeted and effective therapies. While the research is still in its early stages, the innovative approach and multidisciplinary collaboration hold significant promise for advancing the field of cancer research and improving outcomes for patients with glioblastoma.
What comes next: The research team will now focus on establishing the necessary laboratory infrastructure and recruiting personnel. The initial phase will involve refining the 3D bioprinting techniques and optimizing the quantum light-based imaging system. Data collection and analysis are expected to begin within the next year, with preliminary findings anticipated in the following years. The project’s progress will be regularly evaluated, and findings will be disseminated through scientific publications and presentations.